Sang and colleagues found that tumor suppressive miR-519d or siRhoC co-transfection reversed E2F1 oncogenic effects in ovarian cancer cells (increased RhoC, Bcl-2, cyclin D1, survivin, MMP2, MMP9, STAT3, and HuR) [217]. The gene discussed is RHOC; the disease is ovarian carcinoma.